BFM
AGIO icon

Boothbay Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

Boothbay Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-290,900
Closed -$11.7M – 1923
2025
Q3 		$11.7M Buy
+290,900
New +$10.9M 0.17% 124
2021
Q3 		– Sell
-7,600
Closed -$419K – 1865
2021
Q2 		$419K Buy
7,600
+7,504
+7,817% +$420K 0.01% 1095
2021
Q1 		$496K Buy
+96
New +$4.75K 0.02% 954
2019
Q3 		– Sell
-93
Closed -$464K – 753
2019
Q2 		$464K Sell
93
-220
-70% -$11.8K 0.04% 432
2019
Q1 		$2.11M Buy
+313
New +$18.2K 0.2% 114
2016
Q2 		– Sell
-13,700
Closed -$556K – 503
2016
Q1 		$556K Buy
+13,700
New +$586K 0.42% 51

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Boothbay Fund Management's AGIO Position: Q1 2026 in Review

Boothbay Fund Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 37,291 shares — an estimated $1.06M sold.

Boothbay Fund Management first reported a position in AGIO in Q1 2021 and held it in 13 quarters. The position peaked at $19.9M in Q3 2025. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Boothbay Fund Management reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 37,291 Agios Pharmaceuticals shares in Q1 2026, an estimated $1.06M.
  • Boothbay Fund Management first reported a position in Agios Pharmaceuticals in Q1 2021 and held it in 13 quarters.
  • Boothbay Fund Management's Agios Pharmaceuticals position peaked at $19.9M in Q3 2025.
  • 232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.